Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · IEX Real-Time Price · USD
8.75
-0.03 (-0.34%)
May 3, 2024, 10:01 AM EDT - Market open
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $127.39 million as of May 3, 2024. Its market cap has increased by 176.34% in one year.
Market Cap
127.39M
Enterprise Value
95.06M
1-Year Change
176.34%
Ranking
Category
Stock Price
$8.75
Market Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $48.27M to $127.39M, an increase of 163.94%. That is a compound annual growth rate of 106.05%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 2, 2024 | 127.70M | 1.27% |
May 1, 2024 | 126.10M | -4.18% |
Apr 30, 2024 | 131.60M | 7.96% |
Apr 29, 2024 | 121.90M | -2.56% |
Apr 26, 2024 | 125.10M | 2.04% |
Apr 25, 2024 | 122.60M | 0.25% |
Apr 24, 2024 | 122.30M | 4.89% |
Apr 23, 2024 | 116.60M | 0.34% |
Apr 22, 2024 | 116.20M | -0.09% |
Apr 19, 2024 | 116.30M | -5.22% |
Apr 18, 2024 | 122.70M | 2.42% |
Apr 17, 2024 | 119.80M | 0.84% |
Apr 16, 2024 | 118.80M | -2.38% |
Apr 15, 2024 | 121.70M | -7.24% |
Apr 12, 2024 | 131.20M | -1.28% |
Apr 11, 2024 | 132.90M | -1.12% |
Apr 10, 2024 | 134.40M | -1.18% |
Apr 9, 2024 | 136.00M | -3.00% |
Apr 8, 2024 | 140.20M | 0.86% |
Apr 5, 2024 | 139.00M | 4.35% |
Apr 4, 2024 | 133.20M | -7.56% |
Apr 3, 2024 | 144.10M | -0.35% |
Apr 2, 2024 | 144.60M | 1.47% |
Apr 1, 2024 | 142.50M | -1.25% |
Mar 28, 2024 | 144.30M | 2.85% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
So-Young International | 136.63M |
Seer, Inc. | 134.73M |
InterCure | 133.07M |
YS Biopharma Co. | 132.58M |
Augmedix | 132.08M |
Cardiol Therapeutics | 130.88M |
Repare Therapeutics | 130.76M |
VistaGen Therapeutics | 130.53M |